Neomatrix
Pre-clinical21 November, 2024Neomatrix Secures EUR 1.5 Million in Funding to Advance Personalized Cancer Vaccine Development
Founded
2015
Focus
Vaccines
About
21 November, 2024Neomatrix Secures EUR 1.5 Million in Funding to Advance Personalized Cancer Vaccine Development
Company Info
TypePrivate
Founded2015
LocationMilan, Italy
StagePre-clinical
Contact
SIMILAR COMPANIES
AAVantgarde Bio
Pre-clinical · Milan
AB ANALITICA
Pre-clinical · Padua
BetaGlue Therapeutics
Phase 1 · Milan
Adienne Pharma and Biotech
Pre-clinical · Milan
Advaxia Biologics
Pre-clinical · Milan
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile